EN 14476:2013 – Virucidal Testing of Disinfectants and Antiseptics
Overview
The EN 14476:2013 standard outlines a quantitative suspension test for assessing the virucidal effectiveness of chemical disinfectants and antiseptics. This test is crucial for manufacturers aiming to prove that their products effectively tackle viral threats in medical and public health contexts. By simulating real-world conditions, the method ensures that the product performs well in both clean and contaminated environments.
This method, EN 14476:2013+A1:2015, adapted from protocol is a European standard that specifies test methods for the efficacy of chemical disinfectants and antiseptics against viruses. It outlines the protocols for determining whether these products are effective in inactivating viruses in various conditions. This standard is crucial for ensuring the safety and effectiveness of disinfectants used in different environments, including healthcare settings and public spaces.
Products eligible for testing
This test is applicable to a broad spectrum of chemical disinfectants and antiseptics, including but not limited to:
- Hygienic hand rubs and hand washes
- Surface disinfectants
- Antiseptics for instrument disinfection (via immersion)
- Textile disinfectants
These products are utilized in various settings, including:
- Medical environments (hospitals, clinics, surgical facilities)
- Public institutions (schools, offices)
- Workplaces and homes
- Laundry facilities
Description of the EN 14476:2013 Test
This test evaluates the efficacy of disinfectants and antiseptics against a specific virus under conditions that mimic real-world usage. The virus is incubated with the disinfectant for designated time periods at controlled temperatures suitable for the test product. The test simulates both clean and contaminated environments by introducing interfering substances such as serum proteins and red blood cells.
To pass the EN 14476:2013 test, a product must demonstrate at least a 4-log reduction in viral titre, indicating a 99.99% reduction of the virus present.
Why Choose Airmid Health Labs for EN 14476:2013 Testing?
At Airmid Health Labs, we provide reliable, third-party validation for the virucidal efficacy of disinfectants and antiseptics. Our testing services help manufacturers meet industry standards and build consumer trust through scientifically backed claims.
Benefits of Testing with Airmid Health Labs
- Prove product effectiveness: Passing this test enables manufacturers to make verifiable antiviral claims about their products, ensuring confidence among consumers and regulatory bodies.
- Adapted to real-world conditions: Our testing process mirrors both clean and dirty environments to ensure products perform under realistic usage scenarios.
- Third-party validation: Independent, accredited testing through Airmid Health Labs adds credibility to your product claims, giving you a competitive edge.
Third-Party Validation and Market Advantages
Once your product passes the EN 14476:2013 test, you can label it as tested by Airmid Health Labs, demonstrating its antiviral efficacy. This third-party validation ensures your product meets stringent international standards, helping you stand out in a crowded market where consumers are increasingly demanding reliable, effective disinfectants and antiseptics.
Turnaround Time
At Airmid Health Labs, we understand the importance of delivering timely results. Our testing typically has a turnaround time of 4-6 weeks, ensuring that you can move forward with product development and marketing efficiently.
Get in Touch
Ensure your disinfectant or antiseptic product meets international standards for virucidal efficacy. Contact Airmid Health Labs today to discuss your testing needs and to request a quote for EN 14476:2013 testing.